Fewer Excess Pounds May Mean Fewer Migraines
2:00 PM CDT.
Read article
- Want to Stay Trim? Don’t Eat in the Evening, Study Finds
- Science Finds a Way for Transgender Males to Maintain Fertility
- Extra Calcium Safe for the Aging Eye
- Affordable Care Act Brought Big Benefits to Women: Study
JOURNAL UPDATE
Stricter Gun Laws Tied to Safer High Schools
7:00 PM CDT. Stricter gun laws tied to fewer student reports of being threatened/injured with a weapon at school- Analysis IDs Messages Behind Antivaccination Comments
- Prenatal Pesticide Exposure Linked to Increased Risk for Autism
- ACC: New Guidelines Issued for Primary Prevention of CVD
MONTHLY JOURNAL SUMMARY
February 2019 Briefing - Pharmacy
March 01, 2019. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
MEDICAL FOCUS
Alzheimer’s disease
By Tamer M. Fouad, M.D.Alzheimer’s disease (AD) is the most common cause of dementia in Western countries.
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
